OINCX
Price
$24.44
Change
-$0.07 (-0.29%)
Updated
Aug 15 closing price
Net Assets
43.61B
VVIAX
Price
$70.31
Change
-$0.09 (-0.13%)
Updated
Aug 15 closing price
Net Assets
195.81B
Interact to see
Advertisement

OINCX vs VVIAX

Header iconOINCX vs VVIAX Comparison
Open Charts OINCX vs VVIAXBanner chart's image
JPMorgan Equity Income C
Price$24.44
Change-$0.07 (-0.29%)
VolumeN/A
Net Assets43.61B
Vanguard Value Index Adm
Price$70.31
Change-$0.09 (-0.13%)
VolumeN/A
Net Assets195.81B
OINCX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
OINCX vs. VVIAX commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OINCX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 196B vs. OINCX (43.6B). VVIAX pays higher dividends than OINCX: VVIAX (2.18) vs OINCX (1.02). OINCX was incepted earlier than VVIAX: OINCX (28 years) vs VVIAX (25 years). OINCX (1.45) is less costly to investors than VVIAX (0.05). OINCX is a more actively managed with annual turnover of: 20.00 vs. VVIAX (9.00). OINCX has a lower initial minimum investment than VVIAX: OINCX (1000) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 7.91 vs. OINCX (3.85). VVIAX return over 5 years is better than : 68.54 vs. OINCX (49.44).
OINCXVVIAXOINCX / VVIAX
Total Expense Ratio1.450.052,900%
Annual Report Gross Expense Ratio1.450.052,900%
Fund Existence28 years25 years-
Gain YTD8.0576.517124%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets43.6B196B22%
Annual Yield % from dividends1.022.1847%
Returns for 1 year3.857.9149%
Returns for 3 years11.8125.9346%
Returns for 5 years49.4468.5472%
Returns for 10 years96.31114.6184%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CXW20.820.36
+1.76%
CoreCivic
NBIX132.901.59
+1.21%
Neurocrine Biosciences
ZENV1.640.01
+0.49%
Zenvia
ATYR4.90-0.09
-1.80%
aTyr Pharma Inc
WNW1.69-0.05
-2.80%
Meiwu Technology Company Limited